Moderator: Maurizio Sessa, PharmD – University of Copenhagen
Moderator: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
Speaker: Andrew Bate – GlaxoSmithKline
Speaker: Larus S. Gudmundsson (he/him/his) – University of Iceland
Speaker: David O. Arnar – University of Iceland
Plenary
Moderator: Maurizio Sessa, PharmD – University of Copenhagen
### @@@ Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania ### 1359970###Moderator###Associate Professor of Medicine and Epidemiology###Perelman School of Medicine at the University of Pennsylvania###Moderator: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/his @@@ Andrew Bate – GlaxoSmithKline ### 1088314###Speaker###VP & Head, Safety Innovation & Analytics, Global Safety###GlaxoSmithKline###Speaker: Andrew Bate – GlaxoSmithKline
### @@@ Larus S. Gudmundsson (he/him/his) – University of Iceland ### 1901667###Speaker###Associate Professor###University of Iceland###Speaker: Larus S. Gudmundsson (he/him/his) – University of Iceland
### he/him/his @@@ David O. Arnar – University of Iceland ### 1901688###Speaker###Professoe###University of Iceland###Speaker: David O. Arnar – University of Iceland
###Moderator: Andrew Bate – GlaxoSmithKline
Moderator: Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP – Research Triangle Institute
Speaker: Alison Cave, PhD – Medicines and Healthcare products Regulatory Agency (UK)
Speaker: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
Speaker: Jamie Geier (she/her/hers) – Novartis Pharma AG
Plenary
Moderator: Andrew Bate – GlaxoSmithKline
### @@@ Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP – Research Triangle Institute ### 1061396###Moderator###VP Epidemiology###Research Triangle Institute###Moderator: Susana Perez-Gutthann, MD, MPH, PhD, FISPE, FRCP – Research Triangle Institute
### @@@ Alison Cave, PhD – Medicines and Healthcare products Regulatory Agency (UK) ### 1901771###Speaker###Chief Safety Officer###Medicines and Healthcare products Regulatory Agency (UK)###Speaker: Alison Cave, PhD – Medicines and Healthcare products Regulatory Agency (UK)
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Speaker###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Speaker: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ Jamie Geier (she/her/hers) – Novartis Pharma AG ### 1359033###Speaker###Global Head, Quantitative Safety & Epidemiology###Novartis Pharma AG###Speaker: Jamie Geier (she/her/hers) – Novartis Pharma AG
### she/her/hersModerator: Freyja Jonsdottir, MSc (she/her/hers) – Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland; Hospital Pharmacy Landspítali–The National University Hospital, Reykjavík, Iceland
Moderator: Jessica C. Young, PhD (she/her/hers) – Karolinska Institutet
Drug utilization
Moderator: Freyja Jonsdottir, MSc (she/her/hers) – Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland; Hospital Pharmacy Landspítali–The National University Hospital, Reykjavík, Iceland
Moderator: Jessica C. Young, PhD (she/her/hers) – Karolinska Institutet
Drug utilization
Moderator: Freyja Jonsdottir, MSc (she/her/hers) – Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland; Hospital Pharmacy Landspítali–The National University Hospital, Reykjavík, Iceland
### she/her/hers @@@ Jessica C. Young, PhD (she/her/hers) – Karolinska Institutet ### 1932107###Moderator###Postdoctoral Researcher###Karolinska Institutet###Moderator: Jessica C. Young, PhD (she/her/hers) – Karolinska Institutet
### she/her/hersPresenting Author: Kamika Reynolds, PhD – Sanofi
Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
Drug Utilization/Health Services Research
Presenting Author: Kamika Reynolds, PhD – Sanofi
### @@@ Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ ### 1655382###Author###Assistant Professor of Pharmacy and Epidemiology###Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ###Author: Chintan Dave, PharmD, PhD – Center for Pharmacoepidemiology and Treatment Science, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, NJ
###Presenting Author: Þorsteinn Ívar Albertsson, BSc (he/him/his) – Faculty of Medicine, University of Iceland, Reykjavík, Iceland
Author: Freyja Jonsdottir, MSc (she/her/hers) – Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland; Hospital Pharmacy Landspítali–The National University Hospital, Reykjavík, Iceland
Author: Sigurbergur Kárason, MD, PhD, EMPH – Faculty of Medicine, University of Iceland, Reykjavík, Iceland; Department of Anesthesiology and Critical Care Medicine, Landspitali–The National University Hospital, Reykjavík, Iceland.
Author: Martin Ingi I. Sigurdsson, MD, PhD (he/him/his) – Faculty of Medicine, University of Iceland, Reykjavík, Iceland; Department of Anesthesiology and Critical Care Medicine, Landspitali–The National University Hospital, Reykjavík, Iceland.
Drug Utilization/Health Services Research
Presenting Author: Þorsteinn Ívar Albertsson, BSc (he/him/his) – Faculty of Medicine, University of Iceland, Reykjavík, Iceland
### he/him/his @@@ Freyja Jonsdottir, MSc (she/her/hers) – Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland; Hospital Pharmacy Landspítali–The National University Hospital, Reykjavík, Iceland ### 1900348###Author###Assistant Professor, University of Iceland; Clinical Pharmacist, Landspitali University Hospita.###Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland; Hospital Pharmacy Landspítali–The National University Hospital, Reykjavík, Iceland###Author: Freyja Jonsdottir, MSc (she/her/hers) – Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavík, Iceland; Hospital Pharmacy Landspítali–The National University Hospital, Reykjavík, Iceland
### she/her/hers @@@ Sigurbergur Kárason, MD, PhD, EMPH – Faculty of Medicine, University of Iceland, Reykjavík, Iceland; Department of Anesthesiology and Critical Care Medicine, Landspitali–The National University Hospital, Reykjavík, Iceland. ### 1900385###Author###Professor, University of Iceland; Head of Anaesthesia, Landspitali University Hospital.###Faculty of Medicine, University of Iceland, Reykjavík, Iceland; Department of Anesthesiology and Critical Care Medicine, Landspitali–The National University Hospital, Reykjavík, Iceland.###Author: Sigurbergur Kárason, MD, PhD, EMPH – Faculty of Medicine, University of Iceland, Reykjavík, Iceland; Department of Anesthesiology and Critical Care Medicine, Landspitali–The National University Hospital, Reykjavík, Iceland.
### @@@ Martin Ingi I. Sigurdsson, MD, PhD (he/him/his) – Faculty of Medicine, University of Iceland, Reykjavík, Iceland; Department of Anesthesiology and Critical Care Medicine, Landspitali–The National University Hospital, Reykjavík, Iceland. ### 1900347###Author###Professor, University of Iceland; Chief Physician, Landspitali University Hospital.###Faculty of Medicine, University of Iceland, Reykjavík, Iceland; Department of Anesthesiology and Critical Care Medicine, Landspitali–The National University Hospital, Reykjavík, Iceland.###Author: Martin Ingi I. Sigurdsson, MD, PhD (he/him/his) – Faculty of Medicine, University of Iceland, Reykjavík, Iceland; Department of Anesthesiology and Critical Care Medicine, Landspitali–The National University Hospital, Reykjavík, Iceland.
### he/him/hisPresenting Author: Jeff Y. Yang, MSPH (he/him/his) – GSK
Author: Jennifer L. Lund, PhD, FISPE (she/her/hers) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
Author: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health
Author: Michael Hudgens, PhD – Gillings School of Global Public Health, University of North Carolina at Chapel Hill
Author: James D. Lewis, MD MSCE – Division of Gastroenterology and Hepatology, Perelman School of Medicine at the University of Pennsylvania
Author: Michael D. Kappelman, MD, MPH – Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC
Drug Utilization/Health Services Research
Presenting Author: Jeff Y. Yang, MSPH (he/him/his) – GSK
### he/him/his @@@ Jennifer L. Lund, PhD, FISPE (she/her/hers) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1062592###Author###Associate Professor###Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Author: Jennifer L. Lund, PhD, FISPE (she/her/hers) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### she/her/hers @@@ Michele Jonsson Funk, PhD, FISPE (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health ### 1046824###Author###Associate Professor###UNC Chapel Hill Gillings School of Global Public Health###Author: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health
### she/her/hers @@@ Michael Hudgens, PhD – Gillings School of Global Public Health, University of North Carolina at Chapel Hill ### 1358428###Author###Professor and Associate Chair###Gillings School of Global Public Health, University of North Carolina at Chapel Hill###Author: Michael Hudgens, PhD – Gillings School of Global Public Health, University of North Carolina at Chapel Hill
### @@@ James D. Lewis, MD MSCE – Division of Gastroenterology and Hepatology, Perelman School of Medicine at the University of Pennsylvania ### 1900328###Author###Professor of Medicine and Epidemiology###Division of Gastroenterology and Hepatology, Perelman School of Medicine at the University of Pennsylvania###Author: James D. Lewis, MD MSCE – Division of Gastroenterology and Hepatology, Perelman School of Medicine at the University of Pennsylvania
### @@@ Michael D. Kappelman, MD, MPH – Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC ### 1359502###Author###Professor###Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC###Author: Michael D. Kappelman, MD, MPH – Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC
###Presenting Author: Basavaraj Ramappa Poojar, Msc Medical Pharmacology, Final year PhD (he/him/his) – Kasturba Medical College, Light House Hill Road, Mangalore
Author: Ashok Shenoy K (he/him/his) – Kasturba Medical College, Light House Hill Road, Mangalore
Author: Ashwin Kamath, MD (he/him/his) – Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal
Author: John Ramapuram (he/him/his) – Kasturba Medical College, Light House Hill Road, Mangalore
Author: Sathish B Rao (he/him/his) – Kasturba Medical College, Light House Hill Road, Mangalore
Drug-Drug Interaction
Presenting Author: Basavaraj Ramappa Poojar, Msc Medical Pharmacology, Final year PhD (he/him/his) – Kasturba Medical College, Light House Hill Road, Mangalore
### he/him/his @@@ Ashok Shenoy K (he/him/his) – Kasturba Medical College, Light House Hill Road, Mangalore ### 1900313###Author###Professor,###Kasturba Medical College, Light House Hill Road, Mangalore###Author: Ashok Shenoy K (he/him/his) – Kasturba Medical College, Light House Hill Road, Mangalore
### he/him/his @@@ Ashwin Kamath, MD (he/him/his) – Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal ### 1062820###Author###Associate Professor,###Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal###Author: Ashwin Kamath, MD (he/him/his) – Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal
### he/him/his @@@ John Ramapuram (he/him/his) – Kasturba Medical College, Light House Hill Road, Mangalore ### 1900314###Author###Professor,###Kasturba Medical College, Light House Hill Road, Mangalore###Author: John Ramapuram (he/him/his) – Kasturba Medical College, Light House Hill Road, Mangalore
### he/him/his @@@ Sathish B Rao (he/him/his) – Kasturba Medical College, Light House Hill Road, Mangalore ### 1900315###Author###Professor,###Kasturba Medical College, Light House Hill Road, Mangalore###Author: Sathish B Rao (he/him/his) – Kasturba Medical College, Light House Hill Road, Mangalore
### he/him/hisPresenting Author: Meghan Cupp Buxton, BSc, MPH (she/her/hers) – Department of Epidemiology, Brown University School of Public Health
Author: Francesca L. Beaudoin, MD, PhD – Department of Epidemiology, Brown University School of Public Health
Author: Kaleen N. Hayes, PharmD, PhD (she/her/hers) – Brown University School of Public Health, Providence, Rhode Island, USA
Author: Melissa R. Riester, PharmD – Brown University School of Public Health
Author: Sarah Berry, MD, MPH – Department of Medicine, Beth Israel Deaconess Medical Center
Author: Richa Joshi, MS, MBA – Department of Health Services, Policy, and Practice, Brown University School of Public Health
Author: Andrew R. Zullo, PharmD, PhD (he/him/his) – Brown University School of Public Health
Geriatric Pharmacoepidemiology
Presenting Author: Meghan Cupp Buxton, BSc, MPH (she/her/hers) – Department of Epidemiology, Brown University School of Public Health
### she/her/hers @@@ Francesca L. Beaudoin, MD, PhD – Department of Epidemiology, Brown University School of Public Health ### 1358486###Author###Associate Professor###Department of Epidemiology, Brown University School of Public Health###Author: Francesca L. Beaudoin, MD, PhD – Department of Epidemiology, Brown University School of Public Health
### @@@ Kaleen N. Hayes, PharmD, PhD (she/her/hers) – Brown University School of Public Health, Providence, Rhode Island, USA ### 1062830###Author###Assistant Professor###Brown University School of Public Health, Providence, Rhode Island, USA###Author: Kaleen N. Hayes, PharmD, PhD (she/her/hers) – Brown University School of Public Health, Providence, Rhode Island, USA
### she/her/hers @@@ Melissa R. Riester, PharmD – Brown University School of Public Health ### 1302727###Author###Research Scientist###Brown University School of Public Health###Author: Melissa R. Riester, PharmD – Brown University School of Public Health
### @@@ Sarah Berry, MD, MPH – Department of Medicine, Beth Israel Deaconess Medical Center ### 1659409###Author###Associate Professor of Medicine###Department of Medicine, Beth Israel Deaconess Medical Center###Author: Sarah Berry, MD, MPH – Department of Medicine, Beth Israel Deaconess Medical Center
### @@@ Richa Joshi, MS, MBA – Department of Health Services, Policy, and Practice, Brown University School of Public Health ### 1655733###Author###Data Science Analyst###Department of Health Services, Policy, and Practice, Brown University School of Public Health###Author: Richa Joshi, MS, MBA – Department of Health Services, Policy, and Practice, Brown University School of Public Health
### @@@ Andrew R. Zullo, PharmD, PhD (he/him/his) – Brown University School of Public Health ### 1302736###Author###Associate Professor###Brown University School of Public Health###Author: Andrew R. Zullo, PharmD, PhD (he/him/his) – Brown University School of Public Health
### he/him/hisModerator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
Moderator: Claudia Bruno, BSc(hon) (she/her/hers) – School of Population Health, University of New South Wales; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
Informing regulators & improving methods
Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
Moderator: Claudia Bruno, BSc(hon) (she/her/hers) – School of Population Health, University of New South Wales; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
Informing regulators & improving methods
Moderator: Deborah Layton, PhD, FISPE – PEPI Consultancy Limited
### @@@ Claudia Bruno, BSc(hon) (she/her/hers) – School of Population Health, University of New South Wales; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway ### 1062978###Moderator###PhD candidate###School of Population Health, University of New South Wales; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway###Moderator: Claudia Bruno, BSc(hon) (she/her/hers) – School of Population Health, University of New South Wales; Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
### she/her/hersPresenting Author: Christine C. van Hattem, MSc – Utrecht University
Author: Amos de Jong, Msc – Utrecht University
Author: Jolien S. de Groot, MD, PhD – Dutch Medicines Evaluation Board
Author: Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
Cancer
Presenting Author: Christine C. van Hattem, MSc – Utrecht University
### @@@ Amos de Jong, Msc – Utrecht University ### 1657663###Author###PhD student###Utrecht University###Author: Amos de Jong, Msc – Utrecht University
### @@@ Jolien S. de Groot, MD, PhD – Dutch Medicines Evaluation Board ### 1900383###Author###Clinical Assessor###Dutch Medicines Evaluation Board###Author: Jolien S. de Groot, MD, PhD – Dutch Medicines Evaluation Board
### @@@ Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1063247###Author###Assistant Professor Clinical Therapeutics###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Author: Lourens T. Bloem, PharmD, PhD (he/him/his) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### he/him/hisPresenting Author: Renske Grupstra (she/her/hers) – Utrecht University
Author: Thomas Goedecke, Dr. – European Medicines Agency
Author: Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University
Comparative Effectiveness Research (CER)
Presenting Author: Renske Grupstra (she/her/hers) – Utrecht University
### she/her/hers @@@ Thomas Goedecke, Dr. – European Medicines Agency ### 1659475###Author###Senior Pharmacovigilance Specialist###European Medicines Agency###Author: Thomas Goedecke, Dr. – European Medicines Agency
### @@@ Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University ### 1061395###Author###Associate professor###Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University###Author: Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University
###Presenting Author: Sharon CM Essink, MSc (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.
Author: Inge M. Zomerdijk – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.
Author: Sabine MJM Straus, MD, PhD – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands. Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.
Author: Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University
Author: Marie Louise L. De Bruin, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
Benefit Risk Assessment, Communication and Evaluation (BRACE)
Presenting Author: Sharon CM Essink, MSc (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.
### she/her/hers @@@ Inge M. Zomerdijk – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands. ### 1659068###Author###Senior Pharmacovigilance assessor###Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.###Author: Inge M. Zomerdijk – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands.
### @@@ Sabine MJM Straus, MD, PhD – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands. Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands. ### 1094834###Author###Chair of PRAC, associate professor###Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands. Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.###Author: Sabine MJM Straus, MD, PhD – Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands. Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.
### @@@ Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University ### 1061395###Author###Associate professor###Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University###Author: Helga Gardarsdottir, PharmD, PhD, – Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University
### @@@ Marie Louise L. De Bruin, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University ### 1360157###Author###Professor###Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University###Author: Marie Louise L. De Bruin, PhD (she/her/hers) – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
### she/her/hersPresenting Author: Steve Ferreira Guerra – McGill University
Author: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
Author: Michal Abrahamowicz, PhD – McGill University
Adherence
Presenting Author: Steve Ferreira Guerra – McGill University
### @@@ Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada ### 1358167###Author###Professor###Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada###Author: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada
### he/him/his @@@ Michal Abrahamowicz, PhD – McGill University ### 1358206###Author###Professor###McGill University###Author: Michal Abrahamowicz, PhD – McGill University
###Presenting Author: Núria Mercadé Besora (she/her/hers) – IDIAP Jordi Gol
Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
Author: Elena Roel, MD – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
Author: Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
Author: Clara Prats, PHD (she/her/hers) – Universitat Politècnica de Catalunya
Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
Author: Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
Vaccines
Presenting Author: Núria Mercadé Besora (she/her/hers) – IDIAP Jordi Gol
### she/her/hers @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his @@@ Elena Roel, MD – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol) ### 1360486###Author###PhD student###Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)###Author: Elena Roel, MD – Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
### @@@ Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358614###Author###Lead Health Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Author: Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### she/her/hers @@@ Clara Prats, PHD (she/her/hers) – Universitat Politècnica de Catalunya ### 1358939###Author###Professor and Researcher###Universitat Politècnica de Catalunya###Author: Clara Prats, PHD (she/her/hers) – Universitat Politècnica de Catalunya
### she/her/hers @@@ Annika M. Jödicke, PhD (she/her/hers) – University of Oxford ### 1358980###Author###Senior Researcher in Pharmacoepidemiology###University of Oxford###Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1659148###Author###Senior Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Author: Martí Català Sabaté, PhD (he/him/his) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### he/him/hisPresenting Author: Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
Author: Yaqing Gao, MPH – Oxford University
Author: Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
Author: Sara Khalid, PhD – Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
Author: Gary S. Collins, PhD – Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford
Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
Databases
Presenting Author: Junqing Xie, MBBS, MSc, DPhil – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Yaqing Gao, MPH – Oxford University ### 1900270###Author###Doctoral student###Oxford University###Author: Yaqing Gao, MPH – Oxford University
### @@@ Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358614###Author###Lead Health Data Scientist###Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Author: Antonella Delmestri, PhD (she/her/hers) – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### she/her/hers @@@ Sara Khalid, PhD – Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford ### 1358353###Author###Associate Professor###Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford###Author: Sara Khalid, PhD – Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford
### @@@ Gary S. Collins, PhD – Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford ### 1358613###Author###Professor###Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford###Author: Gary S. Collins, PhD – Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford
### @@@ Annika M. Jödicke, PhD (she/her/hers) – University of Oxford ### 1358980###Author###Senior Researcher in Pharmacoepidemiology###University of Oxford###Author: Annika M. Jödicke, PhD (she/her/hers) – University of Oxford
### she/her/hers @@@ Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University ### 1062615###Author###Professor of Pharmaco- and Device Epidemiology, Professor of RWE###University of Oxford, Erasmus MC University###Author: Daniel Prieto-Alhambra, MD MSc(Oxon) PhD (he/him/his) – University of Oxford, Erasmus MC University
### he/him/his